In focus · trending topic

Phase II Clinical Trial

1 stories · following the connections

Factor Therapeutics Announces Commencement of Phase II Trial of a Novel Topical Biologic for the Treatment of Chronic Wounds

By Nasdaq OMXDec 20, 2016, 2:00 PM UTC